-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
3 Healthcare Stocks to Sell in August Before They Crash & Burn
Investors are looking to the healthcare sector for safe harbor. But these are three healthcare stocks to sell in August 2024.
3 Gene Editing Stocks with Potential to Transform Medicine
Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Presidential Election Predictions: 4 Sectors to Invest in as Odds Shift to Blue
According to predictive markets, presidential election odds are favoring a Kamala Harris victory. Here's what this means for investors.
Why Is Iovance Bio (IOVA) Stock Up 18% Today?
Iovance Biotherapeutics stock is gaining as IOVA investors react to strong Q2 earnings beats and positive guidance for 2024 and 2025.
Why Is Doximity (DOCS) Stock Up 30% Today?
Doximity stock is up on Friday as DOCS investors react to earnings and revenue beats alongside strong fiscal 2025 guidance.
FSD Pharma Is Up 216% Today. What Is Going On With HUGE Stock?
FSD Pharma stock is up on Friday as HUGE investors react to an update on its investment in Celly Nutrition and a new product launch.
Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today?
AN2 Therapeutics stock is down on Friday after ANTX investors learned of the company terminating its EBO-301 Phase 2/3 clinical trial.
LLY Stock Alert: Why Are Eli Lilly Shares Surging Today?
Eli Lilly's growth should accelerate now that shortages of its GLP-1 drugs are resolved, but competitors are coming.
Why Is Outset Medical (OM) Stock Down 34% Today?
Outset Medical stock is dropping hard on Thursday as OM investors react to the company's lackluster earnings report for Q2.
Why Is Anew Medical (WENA) Stock Up 37% Today?
Anew Medical stock is up on Thursday with heavy trading of WENA shares despite a lack of news from the biopharmaceutical company.
3 Small-Cap Stocks to Buy Amid the Great Rotation
Any of these small-cap stocks would be a welcome addition to an investment portfolio and offer big growth potential.
Why Is Conduit Pharmaceuticals (CDT) Stock Up 123% Today?
Conduit Pharmaceuticals stock is up on Thursday with heavy trading of CDT shares after the company announce a new license agreement.
3 High-Growth Dividend Stocks to Own for the Next 10 Years
Discover the best high-growth dividend stocks with strong fundamentals across integrated telecommunication, retail REITs, and pharmaceuticals.
The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024
Explore the best dividend payouts from leading companies for sustainable, steady and growing income streams.
3 Biotech Stocks With Promising Drug Pipelines: August 2024
The biotech stocks with promising pipelines could see shares soar if drugs in late-stage trials get FDA approval.
The 3 Best Biotech Stocks to Buy in August 2024
These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead.
7 Biotech Stocks to Buy for Their Game-Changing Potential
Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks.
Biotech News: Why Is Aditxt (ADTX) Stock Up 49% Today?
Aditxt stock is up on Wednesday with heavy trading of ADTX shares following a clinical proposal from a subsidiary.
NVO Stock Alert: Why Is Novo Nordisk Down 8% Today?
Novo Nordisk stock is down on Wednesday with a Q2 revenue miss as the company disappoints NVO investors despite Wegovy demand increasing.
3 Healthcare Stocks Positioned for Possible Market Outperformance
While healthcare stocks might not be as shiny as they were in the pandemic era, these three could outperform the broader market.
